R Michael Carruthers

R Michael Carruthers has an estimated net worth of $7.37 Million. This is based on reported shares across multiple companies, which include Nivalis Therapeutics, Inc., Edgewise Therapeutics, Inc., Elevation Oncology, Inc., Brickell Biotech, Inc., and OnKure Therapeutics, Inc..

2024 was R Michael Carruthers's most active year for acquiring shares with 13 total transactions. R Michael Carruthers's most active month to acquire stocks was the month of July. 2024 was R Michael Carruthers's most active year for disposing of shares, totalling 10 transactions. R Michael Carruthers's most active month to dispose stocks was the month of April. 2024 saw R Michael Carruthers paying a total of $408,811.24 for 481,474 shares, this is the most they've acquired in one year. In 2024 R Michael Carruthers cashed out on 478,525 shares for a total of $5,034,527.80, their largest year based on trade value.